Judi Health, a prominent health technology firm and benefits administrator formerly known as Capital Rx, has announced a significant expansion of its clinical partner ecosystem through the integration of three specialized health providers: Color Health, WellTheory, and Cylinder. This strategic move, announced on Thursday, aims to provide employers, unions, and health plans with a more […]
The biopharmaceutical landscape for rare neurological disorders faced a significant setback this week as Ultragenyx Pharmaceutical announced that its late-stage clinical trial for apazunersen, a potential treatment for Angelman syndrome, failed to meet its primary and key secondary endpoints. The announcement, made following the close of market on Wednesday, marks a pivotal moment for the […]
Teva Pharmaceutical Industries has announced successful topline results from a Phase 2a clinical trial evaluating TEV-53408, an experimental anti-IL-15 monoclonal antibody, in patients with celiac disease. The study met its primary endpoint, demonstrating that the drug significantly prevented intestinal damage in patients exposed to gluten compared to those receiving a placebo. This milestone represents a […]
The Nashville-based oncology management platform Thyme Care announced on Wednesday that it has successfully closed a $125 million Series E financing round, a significant milestone that elevates the company’s valuation to over $2 billion. This infusion of capital marks a pivotal moment for the four-year-old organization as it transitions from a specialized care navigation service […]
The landscape of pulmonary diagnostics in the United States is facing a critical bottleneck characterized by high procedural volume and a persistently high rate of complications. Every two minutes, an individual in the U.S. receives a lung cancer diagnosis, a statistic that underscores the urgent necessity for efficient, accurate diagnostic pathways. For the vast majority […]
Healthcare has reached a critical juncture with artificial intelligence, where rapid technological advances are increasingly clashing with stagnant financial and operational outcomes. While the promise of AI to revolutionize medicine is undisputed, many healthcare organizations are finding that their massive investments are failing to yield the expected returns. This disconnect is not necessarily a failure […]
The global clinical development industry has reached a critical inflection point where the "complexity tax"—a term used to describe the mounting friction, costs, and delays inherent in modern drug trials—is no longer being viewed as an unavoidable cost of doing business but as a systemic failure that requires a fundamental technological overhaul. For decades, the […]
The U.S. Department of Health and Human Services (HHS) has formally announced the distribution of $77 million in new grant funding aimed at bolstering the nation’s behavioral health infrastructure. This significant financial injection, orchestrated through the Substance Abuse and Mental Health Services Administration (SAMHSA), is earmarked for a comprehensive suite of services including substance use […]
In a strategic move aimed at dismantling the data silos that have long hindered rare disease research, two prominent Irish health technology startups, Cushla and Clirinx, have announced a formal merger. The consolidation of these two entities is designed to provide patients with a single, continuous health and research record, effectively ending the redundant cycle […]
Pharmaceutical giant GSK has officially announced its intention to transition its experimental messenger RNA (mRNA) seasonal influenza vaccine into a pivotal Phase 3 clinical trial. This decision follows the release of positive Phase 2 data, which demonstrated that the vaccine candidate generated superior immune responses across all tested influenza strains when compared to currently available […]
